Logo image of ABI.BR

ANHEUSER-BUSCH INBEV SA/NV (ABI.BR) Stock Fundamental Analysis

Europe - EBR:ABI - BE0974293251 - Common Stock

53.36 EUR
+0.46 (+0.87%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

4

Overall ABI gets a fundamental rating of 4 out of 10. We evaluated ABI against 29 industry peers in the Beverages industry. ABI has a medium profitability rating, but doesn't score so well on its financial health evaluation. ABI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ABI was profitable.
In the past year ABI had a positive cash flow from operations.
Each year in the past 5 years ABI has been profitable.
In the past 5 years ABI always reported a positive cash flow from operatings.
ABI.BR Yearly Net Income VS EBIT VS OCF VS FCFABI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.37%, ABI is doing worse than 62.07% of the companies in the same industry.
With a Return On Equity value of 8.82%, ABI perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
ABI's Return On Invested Capital of 6.35% is in line compared to the rest of the industry. ABI outperforms 41.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABI is below the industry average of 8.16%.
The 3 year average ROIC (6.05%) for ABI is below the current ROIC(6.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.37%
ROE 8.82%
ROIC 6.35%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ABI.BR Yearly ROA, ROE, ROICABI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 12.16%, ABI is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
ABI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 26.51%, ABI is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
In the last couple of years the Operating Margin of ABI has declined.
The Gross Margin of ABI (55.70%) is better than 62.07% of its industry peers.
ABI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 26.51%
PM (TTM) 12.16%
GM 55.7%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
ABI.BR Yearly Profit, Operating, Gross MarginsABI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABI is still creating some value.
Compared to 1 year ago, ABI has less shares outstanding
Compared to 5 years ago, ABI has more shares outstanding
Compared to 1 year ago, ABI has an improved debt to assets ratio.
ABI.BR Yearly Shares OutstandingABI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABI.BR Yearly Total Debt VS Total AssetsABI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

ABI has an Altman-Z score of 1.69. This is a bad value and indicates that ABI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ABI (1.69) is worse than 68.97% of its industry peers.
ABI has a debt to FCF ratio of 6.48. This is a slightly negative value and a sign of low solvency as ABI would need 6.48 years to pay back of all of its debts.
The Debt to FCF ratio of ABI (6.48) is better than 68.97% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that ABI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.89, ABI is doing worse than 65.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.48
Altman-Z 1.69
ROIC/WACC1.05
WACC6.05%
ABI.BR Yearly LT Debt VS Equity VS FCFABI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 0.64 indicates that ABI may have some problems paying its short term obligations.
The Current ratio of ABI (0.64) is worse than 89.66% of its industry peers.
A Quick Ratio of 0.48 indicates that ABI may have some problems paying its short term obligations.
ABI's Quick ratio of 0.48 is on the low side compared to the rest of the industry. ABI is outperformed by 75.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.48
ABI.BR Yearly Current Assets VS Current LiabilitesABI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.61% over the past year.
The Earnings Per Share has been decreasing by -1.83% on average over the past years.
The Revenue has decreased by -2.35% in the past year.
The Revenue has been growing slightly by 2.69% on average over the past years.
EPS 1Y (TTM)9.61%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8.89%
Revenue 1Y (TTM)-2.35%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-2.15%

3.2 Future

ABI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.96% yearly.
Based on estimates for the next years, ABI will show a small growth in Revenue. The Revenue will grow by 4.20% on average per year.
EPS Next Y7.4%
EPS Next 2Y9.55%
EPS Next 3Y12.23%
EPS Next 5Y9.96%
Revenue Next Year0.96%
Revenue Next 2Y3.14%
Revenue Next 3Y3.98%
Revenue Next 5Y4.2%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABI.BR Yearly Revenue VS EstimatesABI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B
ABI.BR Yearly EPS VS EstimatesABI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.05 indicates a rather expensive valuation of ABI.
ABI's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.40, ABI is valued a bit cheaper.
A Price/Forward Earnings ratio of 14.76 indicates a correct valuation of ABI.
The rest of the industry has a similar Price/Forward Earnings ratio as ABI.
ABI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.05
Fwd PE 14.76
ABI.BR Price Earnings VS Forward Price EarningsABI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABI is valued a bit cheaper than 68.97% of the companies in the same industry.
ABI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABI is cheaper than 68.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.41
EV/EBITDA 8.89
ABI.BR Per share dataABI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABI does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ABI's earnings are expected to grow with 12.23% in the coming years.
PEG (NY)2.3
PEG (5Y)N/A
EPS Next 2Y9.55%
EPS Next 3Y12.23%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.37%, ABI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.83, ABI is paying slightly less dividend.
With a Dividend Yield of 1.37, ABI pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

The dividend of ABI decreases each year by -12.03%.
Dividend Growth(5Y)-12.03%
Div Incr Years3
Div Non Decr Years4
ABI.BR Yearly Dividends per shareABI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ABI pays out 51.68% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP51.68%
EPS Next 2Y9.55%
EPS Next 3Y12.23%
ABI.BR Yearly Income VS Free CF VS DividendABI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
ABI.BR Dividend Payout.ABI.BR Dividend Payout, showing the Payout Ratio.ABI.BR Dividend Payout.PayoutRetained Earnings

ANHEUSER-BUSCH INBEV SA/NV

EBR:ABI (10/17/2025, 7:00:00 PM)

53.36

+0.46 (+0.87%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners20.3%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap104.19B
Analysts83.13
Price Target68.57 (28.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly Dividend1.17
Dividend Growth(5Y)-12.03%
DP51.68%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.58%
Min EPS beat(2)1.01%
Max EPS beat(2)8.16%
EPS beat(4)4
Avg EPS beat(4)8.8%
Min EPS beat(4)1.01%
Max EPS beat(4)20.27%
EPS beat(8)8
Avg EPS beat(8)7.13%
EPS beat(12)12
Avg EPS beat(12)8.52%
EPS beat(16)14
Avg EPS beat(16)8.77%
Revenue beat(2)0
Avg Revenue beat(2)-2.69%
Min Revenue beat(2)-3.28%
Max Revenue beat(2)-2.1%
Revenue beat(4)1
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)4.57%
Revenue beat(8)2
Avg Revenue beat(8)-1.89%
Revenue beat(12)2
Avg Revenue beat(12)-1.98%
Revenue beat(16)6
Avg Revenue beat(16)-1.07%
PT rev (1m)-2.07%
PT rev (3m)-6.05%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-2.51%
EPS NY rev (1m)0.17%
EPS NY rev (3m)3.14%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE 17.05
Fwd PE 14.76
P/S 2.07
P/FCF 10.41
P/OCF 7.99
P/B 1.5
P/tB N/A
EV/EBITDA 8.89
EPS(TTM)3.13
EY5.87%
EPS(NY)3.62
Fwd EY6.78%
FCF(TTM)5.13
FCFY9.61%
OCF(TTM)6.68
OCFY12.52%
SpS25.73
BVpS35.47
TBVpS-33.06
PEG (NY)2.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.37%
ROE 8.82%
ROCE 8.71%
ROIC 6.35%
ROICexc 6.62%
ROICexgc 76.01%
OM 26.51%
PM (TTM) 12.16%
GM 55.7%
FCFM 19.92%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ROICexc(3y)6.43%
ROICexc(5y)6.06%
ROICexgc(3y)81%
ROICexgc(5y)72.75%
ROCE(3y)8.3%
ROCE(5y)7.79%
ROICexcg growth 3Y11.31%
ROICexcg growth 5Y15.72%
ROICexc growth 3Y4.65%
ROICexc growth 5Y2.73%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.48
Debt/EBITDA 3.44
Cap/Depr 65.6%
Cap/Sales 6.04%
Interest Coverage 4.35
Cash Conversion 72.68%
Profit Quality 163.87%
Current Ratio 0.64
Quick Ratio 0.48
Altman-Z 1.69
F-Score7
WACC6.05%
ROIC/WACC1.05
Cap/Depr(3y)85.67%
Cap/Depr(5y)89.39%
Cap/Sales(3y)7.73%
Cap/Sales(5y)8.33%
Profit Quality(3y)163.01%
Profit Quality(5y)238.24%
High Growth Momentum
Growth
EPS 1Y (TTM)9.61%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8.89%
EPS Next Y7.4%
EPS Next 2Y9.55%
EPS Next 3Y12.23%
EPS Next 5Y9.96%
Revenue 1Y (TTM)-2.35%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-2.15%
Revenue Next Year0.96%
Revenue Next 2Y3.14%
Revenue Next 3Y3.98%
Revenue Next 5Y4.2%
EBIT growth 1Y2.99%
EBIT growth 3Y2.81%
EBIT growth 5Y-1.1%
EBIT Next Year40.29%
EBIT Next 3Y17.25%
EBIT Next 5Y12%
FCF growth 1Y56.54%
FCF growth 3Y6.91%
FCF growth 5Y4.78%
OCF growth 1Y19.49%
OCF growth 3Y0.57%
OCF growth 5Y1.41%